Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

17.50p
   
  • Change Today:
      1.00p
  • 52 Week High: 31.00
  • 52 Week Low: 11.25
  • Currency: UK Pounds
  • Shares Issued: 135.41m
  • Volume: 283,733
  • Market Cap: £23.70m
  • RiskGrade: 594
  • Beta: 0.01

Deal with Barclays    Trade now with Barclays Stockbrokers

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 10.6  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 0.05 (1.12) (1.50)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a 2.58 (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-23 n/a (4.03) (4.70)p n/a n/a n/a n/a 0.0%
30-Jun-24 n/a (4.60) (4.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 n/a (3.76) (2.22)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Sareum Holdings Company Announcements

Sareum Collaboration with Receptor.AI 12-Aug-2025 07:00 RNS
Exercise of Warrants 09-Jul-2025 07:00 RNS
Appointment of Sole Broker 04-Jul-2025 07:00 RNS

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 17.50p
Change Today 1.00p
% Change 6.06 %
52 Week High 31.00
52 Week Low 11.25
Volume 283,733
Shares Issued 135.41m
Market Cap £23.70m
Beta 0.01
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.25% below the market average46.25% below the market average46.25% below the market average46.25% below the market average46.25% below the market average
11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average11.63% above the sector average
Price Trend
78.13% below the market average78.13% below the market average78.13% below the market average78.13% below the market average78.13% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 12-Aug-2025

Time Volume / Share Price
12:11 10,000 @ 17.90p
12:07 2,000 @ 17.90p
12:05 1,000 @ 17.90p
12:04 10,000 @ 17.90p
12:00 2,842 @ 17.00p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page